227 related articles for article (PubMed ID: 21615514)
1. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course.
Masui K; Nakata Y; Fujii N; Iwaki T
Neuropathology; 2012 Feb; 32(1):69-76. PubMed ID: 21615514
[TBL] [Abstract][Full Text] [Related]
2. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.
Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H
Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
Wang Y; Lü C; Ye Z
Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
[TBL] [Abstract][Full Text] [Related]
5. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system).
Ishizawa K; Komori T; Arai N; Mizutani T; Hirose T
Neuropathology; 2008 Jun; 28(3):249-57. PubMed ID: 18312549
[TBL] [Abstract][Full Text] [Related]
6. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
[TBL] [Abstract][Full Text] [Related]
7. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy.
Chiba Y; Takei S; Kawamura N; Kawaguchi Y; Sasaki K; Hasegawa-Ishii S; Furukawa A; Hosokawa M; Shimada A
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):559-71. PubMed ID: 22013984
[TBL] [Abstract][Full Text] [Related]
9. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
[TBL] [Abstract][Full Text] [Related]
10. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of neuronal degeneration of multiple system atrophy].
Yoshida M; Sone M
Brain Nerve; 2009 Sep; 61(9):1051-60. PubMed ID: 19803404
[TBL] [Abstract][Full Text] [Related]
12. Cellular pathology in multiple system atrophy.
Wakabayashi K; Takahashi H
Neuropathology; 2006 Aug; 26(4):338-45. PubMed ID: 16961071
[TBL] [Abstract][Full Text] [Related]
13. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.
Kaji S; Maki T; Ishimoto T; Yamakado H; Takahashi R
Transl Neurodegener; 2020; 9():7. PubMed ID: 32095235
[TBL] [Abstract][Full Text] [Related]
14. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
Mochizuki A; Komatsuzaki Y; Shoji S
Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy.
Kawamoto Y; Akiguchi I; Shirakashi Y; Honjo Y; Tomimoto H; Takahashi R; Budka H
Brain Res; 2007 Mar; 1136(1):219-27. PubMed ID: 17240362
[TBL] [Abstract][Full Text] [Related]
16. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
17. The role of alpha-synuclein in the pathogenesis of multiple system atrophy.
Wenning GK; Jellinger KA
Acta Neuropathol; 2005 Feb; 109(2):129-40. PubMed ID: 15666181
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.
Koga S; Lin WL; Walton RL; Ross OA; Dickson DW
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):707-721. PubMed ID: 29660838
[TBL] [Abstract][Full Text] [Related]
19. Tau-positive glial cytoplasmic granules in multiple system atrophy.
Nagaishi M; Yokoo H; Nakazato Y
Neuropathology; 2011 Jun; 31(3):299-305. PubMed ID: 21062361
[TBL] [Abstract][Full Text] [Related]
20. XIAP immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.
Kawamoto Y; Ito H; Ihara M; Takahashi R
Clin Neuropathol; 2014; 33(1):76-83. PubMed ID: 23993308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
